NCT03422354

Brief Summary

The paravertebral block (PVB) is a block of the mixed nerve soon after it exits the intervertebral foramen.(2) It provides intense unilateral analgesia of long duration and has become the primary anesthetic for many applications.(3) Paravertebral Block (PVB) involves injection of local anaesthetic in a space immediately lateral to where the spinal nerves emerge from the intervertebral foramina. This technique is being used increasingly for not only intra-operative and post-operative analgesia but also as a sole anaesthetic technique for carrying out various procedures. This popularity is mainly due to the ease of the technique and fewer complications.(4) The increasing demand for hip arthroplasties over the last decades has sparked the creation of new and innovative anesthetic techniques and analgesic pathways with the goal to support best possible outcomes among this frequently elderly patient population. As a result, today different perioperative treatment pathways are available to physicians and their patients. In this context, the focus has shifted to techniques based on regional anesthetic and analgesic techniques. This trajectory has been fueled by a number of advantages including effective, long-lasting and focused pain control, decreased need for systemic analgesics and earlier mobilization.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 27, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 5, 2018

Completed
7 days until next milestone

Study Start

First participant enrolled

February 12, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2018

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2018

Completed
Last Updated

May 17, 2018

Status Verified

May 1, 2018

Enrollment Period

3 months

First QC Date

December 27, 2017

Last Update Submit

May 15, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Dose of hypotensive drugs

    Required dose of hypotensive drugs in both groups

    One day postoperatively

Secondary Outcomes (2)

  • Pain assessment

    One day postoperatively

  • Total dose of opioids

    One day postoperatively

Other Outcomes (1)

  • Blood transfusion recorded

    One day postoperatively

Study Arms (2)

Paravertebral block Group

ACTIVE COMPARATOR

Patients will receive single shot L1-L2 PVB before undergoing GA Full monitoring with ECG , NIBP , puls oximetry will be applied. The level between L1 and L2 will be identified using U/S as well as transverse processes depth. Insertion points will be marked 2.5 cm lateral to the superior aspect of corresponding spinous processes, A 22-gauge Tuohy needle will be advanced until it made contact with the transverse process. The needle will be withdrawn slightly and walked off caudally to an additional depth of 1 cm. Once this is reached, 20cc of bupivacaine 0.25% will be injected slowly To control intraoperative blood pressure, fentanyl will be used as well as hypotensive drugs ( propranolol and nitroglycerine and the total dose will be recorded.

Procedure: Ultrasound guided PVB with General AneasthesiaDevice: UltrasoundDrug: Paravertebral blockDrug: General Aneasthesia

General anesthesia Group

ACTIVE COMPARATOR

Patients will receive only GA All patients in the study will receive GA in the form of propofol 2mg/kg , atracurium 0.5ml/kg ,fentanyl 100 microgram in induction with ETT and mechanical ventilation , full monitoring with ECG , NIBP and puls oximetry will be applied. To control intraoperative BP,fentanyl will be used as well as,hypotensive drugs ( propranolol and nitroglycerine and the total dose will be recorded. To achieve post operative analgesia, intravenous paracetamol( 1gram ) and pethidine IV (50 mg ) will be added when needed

Device: UltrasoundDrug: General Aneasthesia

Interventions

An 18G Tuohy needle was inserted perpendicularly at L1,2 to hit the transverse process via an out-of-plane approach. This then directed over the top of the bony structure. The deviation of the needle was kept at 15°. The space was identified using loss of resistance without U/S After negative aspiration, Transverse process visualisation was possible. Distances measured using U/S correlated well with needle depth. Injection of local anaesthetic was visualised as turbulence at L1,2 in all patients. The onset time for this block is 15-25 min

Paravertebral block Group

Ultrasound

General anesthesia GroupParavertebral block Group

Patients will receive single shot L1-L2 PVB before undergoing GA

Paravertebral block Group

General Aneasthesia

General anesthesia GroupParavertebral block Group

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients from 20 to 60 years.
  • Genders eligible for study: both.
  • ASA I-II.
  • No contraindications for application of regional anesthesia as Patient refusal, local anesthetic, allergy, local sepsis or infection at puncture site, INR \> 1.5 or \< 12 hours post LMWH.

You may not qualify if:

  • Extremes of age.
  • ASA III-IV.
  • Hypovolemia.
  • Increased intracranial pressure.
  • Coagulopathy or thrombocytopenia less than 100000/ml.
  • Sepsis (increased risk of meningitis).
  • Infection at the puncture site.
  • Pre-existing neurologic disease.
  • Patient refusal.
  • History of allergy to local anesthetic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed Abdalla Mohamed

Cairo, 11451, Egypt

Location

MeSH Terms

Interventions

Ultrasonography

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Masking Details
The patients were randomized to two groups using a computer-generated list and kept in a sealed envelope into two groups:
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: after approval of the ethical committee (N-73-2017)Which approval date was 12/2/2018 74 patients scheduled for elective hip surgery were included in the study after detailed description and signing a detailed informative consent (figure1). The patients were randomized to two groups using a computer-generated list and kept in a sealed envelope into two groups: * Group P: 37 patients were received single shot L1-L2 paravertebral block before undergoing general anesthesia (GA). * Group G: 37 patients were received GA. The target of the mean blood pressure was to be more than 50mm Hg while the systolic pressure to be between 80 and 100 mm Hg and the diastolic blood pressure targeted to be 50 to 70 mmHg.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Anesthesia&I.C.U and Pain Clinic

Study Record Dates

First Submitted

December 27, 2017

First Posted

February 5, 2018

Study Start

February 12, 2018

Primary Completion

May 10, 2018

Study Completion

May 15, 2018

Last Updated

May 17, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Via scholar Gate

Locations